SSTR2 and neoplasm: Shields et al. found that SSTA recognizes SSTR2 and combines with it to activate tyrosine phosphatase SHP-1, thereby terminating the effects of growth factors and cytokines through dephosphorylation and directly inhibiting tumor cell proliferation [29].